Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience.

Elisa SalaG CarosiG Del SindacoR MungariA CremaschiA L SerbanC L RonchiE FerranteM ArosioG Mantovani

Published in: Journal of endocrinological investigation (2021)

A successful withdrawal of SAs is possible in a subset of well-controlled acromegalic patients and it challenges the concept that medical therapy is a lifelong requirement.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
rheumatoid arthritis